An increased expression of EphA4, EphA7 and EphA10 receptors was also found in breast cancer, which is associated with poor prognosis, and EphA4 is reported to promote breast cancer cell proliferation, migration, and invasion via the transforming growth factor-beta (TGFβ) signalling pathway. This evidence concerns the gene EPHA4 and breast carcinoma.